Association_NP of_IN the_DT Herpes_NP Simplex_NP Virus_NP Type_NP 1_CD Us11_NP Gene_NP Product_NP with_IN the_DT Cellular_NP Kinesin_NP Light-Chain-Related_NP Protein_NP PAT1_NP Results_NNS in_IN the_DT Redistribution_NN of_IN Both_DT Polypeptides_NP The_DT herpes_NN simplex_JJ virus_NN type_NN 1_CD (_( HSV-1_NP )_) Us11_NP gene_NN encodes_VBZ a_DT multifunctional_JJ double-stranded_JJ RNA_NP (dsRNA)-binding_NN protein_NN that_WDT is_VBZ expressed_VBN late_RB in_IN infection_NN and_CC packaged_VBN into_IN the_DT tegument_NN layer_NN of_IN the_DT virus_NN particle_NN ._SENT As_IN a_DT tegument_NN component_NN ,_, Us11_JJ associates_NNS with_IN nascent_JJ capsids_NNS after_IN its_PP$ synthesis_NN late_RB in_IN the_DT infectious_JJ cycle_NN and_CC is_VBZ delivered_VBN into_IN newly_RB infected_VBN cells_NNS at_IN times_NNS prior_RB to_TO the_DT expression_NN of_IN viral_JJ genes_NNS ._SENT Us11_NP is_VBZ also_RB an_DT abundant_JJ late_JJ protein_NN that_WDT regulates_VBZ translation_NN through_IN its_PP$ association_NN with_IN host_NN components_NNS and_CC contains_VBZ overlapping_JJ nucleolar_JJ retention_NN and_CC nuclear_JJ export_NN signals_NNS ,_, allowing_VBG its_PP$ accumulation_NN in_IN both_DT nucleoli_NNS and_CC the_DT cytosol_NN ._SENT Thus_RB ,_, at_IN various_JJ times_NNS during_IN the_DT viral_JJ life_NN cycle_NN and_CC in_IN different_JJ intracellular_JJ compartments_NNS ,_, Us11_NP has_VBZ the_DT potential_NN to_TO execute_VB discrete_JJ tasks_NNS ._SENT The_DT analysis_NN of_IN these_DT functions_NNS ,_, however_RB ,_, is_VBZ complicated_VBN by_IN the_DT fact_NN that_IN Us11_NP is_VBZ not_RB essential_JJ for_IN viral_JJ replication_NN in_IN cultured_JJ cells_NNS ._SENT To_TO discover_VB new_JJ host_NN targets_NNS for_IN the_DT Us11_JJ protein_NN ,_, we_PP searched_VBD for_IN cellular_JJ proteins_NNS that_WDT interact_VBP with_IN Us11_JJ and_CC have_VBP identified_VBN PAT1_JJ as_IN a_DT Us11-binding_JJ protein_NN according_VBG to_TO multiple_JJ ,_, independent_JJ experimental_JJ criteria_NNS ._SENT PAT1_JJ binds_NNS microtubules_NNS ,_, participates_VBZ in_IN amyloid_JJ precursor_NN protein_NN trafficking_NN ,_, and_CC has_VBZ homology_NN to_TO the_DT kinesin_NN light_NN chain_NN (_( KLC_NP )_) in_IN its_PP$ carboxyl_NN terminus_NN ._SENT The_DT carboxyl-terminal_JJ dsRNA-binding_NN domain_NN of_IN Us11_NP ,_, which_WDT also_RB contains_VBZ the_DT nucleolar_JJ retention_NN and_CC nuclear_JJ export_NN signals_NNS ,_, binds_NNS PAT1_JJ ,_, whereas_IN 149_CD residues_NNS derived_VBN from_IN the_DT KLC_NP homology_NN region_NN of_IN PAT1_NP are_VBP important_JJ for_IN binding_VBG to_TO Us11_NP ._SENT Both_DT PAT1_NP and_CC Us11_NP colocalize_VBP within_IN a_DT perinuclear_JJ area_NN in_IN transiently_RB transfected_JJ and_CC HSV-1-infected_JJ cells_NNS ._SENT The_DT 149_CD amino_NN acids_NNS derived_VBN from_IN the_DT KLC_NP homology_NN region_NN are_VBP required_VBN for_IN colocalization_NN of_IN the_DT two_CD polypeptides_NNS ._SENT Furthermore_RB ,_, although_IN PAT1_NP normally_RB accumulates_VBZ in_IN the_DT nuclear_JJ compartment_NN ,_, Us11_JJ expression_NN results_NNS in_IN the_DT exclusion_NN of_IN PAT1_NP from_IN the_DT nucleus_NN and_CC its_PP$ accumulation_NN in_IN the_DT perinuclear_JJ space_NN ._SENT Similarly_RB ,_, Us11_NP does_VBZ not_RB accumulate_VB in_IN the_DT nucleoli_NNS of_IN infected_JJ cells_NNS that_WDT overexpress_VBP PAT1_JJ ._SENT These_DT results_NNS establish_VBP that_IN Us11_NP and_CC PAT1_NP can_MD associate_VB ,_, resulting_VBG in_IN an_DT altered_JJ subcellular_JJ distribution_NN of_IN both_DT polypeptides_NNS ._SENT The_DT association_NN between_IN PAT1_NP ,_, a_DT cellular_JJ trafficking_NN protein_NN with_IN homology_NN to_TO KLC_NP ,_, and_CC Us11_NP ,_, along_RB with_IN a_DT recent_JJ report_NN demonstrating_VBG an_DT interaction_NN between_IN Us11_NP and_CC the_DT ubiquitous_JJ kinesin_NN heavy_JJ chain_NN (_( R._NP J._NP Diefenbach_NP et_FW al._FW ,_, J._NP Virol_NP ._SENT 76:3282-3291_CD ,_, 2002_CD )_) ,_, suggests_VBZ that_IN these_DT associations_NNS may_MD be_VB important_JJ for_IN the_DT intracellular_JJ movement_NN of_IN viral_JJ components_NNS ._SENT Juxtaposed_VBN between_IN the_DT nucleocapsid_NN and_CC the_DT envelope_NN lies_VBZ the_DT tegument_NN ,_, an_DT electron-dense_NN ,_, structured_JJ region_NN within_IN herpesvirus_NN particles_NNS (_( reviewed_VBN in_IN references_NNS and_CC )_) ._SENT Included_VBN among_IN the_DT RNA_NP molecules_NNS and_CC at_IN least_JJS 15_CD polypeptides_NNS that_WDT populate_VBP this_DT zone_NN in_IN HSV-1_JJ virions_NNS is_VBZ the_DT product_NN of_IN the_DT Us11_JJ gene_NN ._SENT As_IN a_DT tegument_NN component_NN ,_, Us11_NP is_VBZ delivered_VBN into_IN the_DT cytosol_NN after_IN fusion_NN of_IN the_DT viral_JJ envelope_NN with_IN the_DT host_NN cell_NN plasma_NN membrane_NN ._SENT Once_RB inside_IN the_DT host_NN cell_NN ,_, viral_JJ tegument_NN components_NNS are_VBP free_JJ ,_, in_IN certain_JJ cases_NNS ,_, to_TO perform_VB a_DT diverse_JJ array_NN of_IN tasks_NNS prior_RB to_TO the_DT onset_NN of_IN viral_JJ gene_NN expression_NN ._SENT Some_DT tegument_NN components_NNS associate_VBP with_IN strategic_JJ host_NN proteins_NNS ,_, thereby_RB modifying_VBG the_DT cellular_JJ environment_NN such_JJ that_IN it_PP supports_VBZ more_JJR efficient_JJ viral_JJ replication_NN ._SENT For_IN example_NN ,_, to_TO facilitate_VB the_DT loading_NN of_IN cellular_JJ ribosomes_NNS onto_IN viral_JJ mRNAs_NNS ,_, the_DT HSV-1_NP Vhs_NP nuclease_NN selectively_RB destabilizes_VBZ mRNAs_NNS through_IN an_DT association_NN with_IN the_DT translation_NN initiation_NN factor_NN eIF4H_NN ._SENT Similarly_RB ,_, VP16_NP ,_, a_DT potent_JJ transcriptional_JJ transactivator_NN ,_, assembles_VBZ into_IN a_DT complex_NN ,_, along_RB with_IN the_DT cellular_JJ transcription_NN factors_NNS HCF-1_NP and_CC Oct-1_NP ,_, to_TO stimulate_VB transcription_NN from_IN viral_JJ immediate-early_JJ promoters_NNS ._SENT Although_IN introduced_VBN into_IN the_DT cytoplasm_NN extremely_RB early_RB in_IN the_DT infectious_JJ cycle_NN ,_, Us11_NP ,_, like_IN many_JJ tegument_NN proteins_NNS ,_, is_VBZ synthesized_VBN late_RB in_IN the_DT viral_JJ life_NN cycle_NN ._SENT In_IN addition_NN ,_, since_IN Us11_NP accumulates_VBZ both_CC in_IN nucleoli_NNS and_CC in_IN the_DT cytosol_NN ,_, it_PP has_VBZ the_DT potential_NN to_TO perform_VB discrete_JJ actions_NNS at_IN different_JJ times_NNS in_IN various_JJ cellular_JJ compartments_NNS ._SENT Deciphering_VBG the_DT functions_NNS executed_VBN by_IN Us11_NP has_VBZ proved_VBN difficult_JJ ,_, since_IN genetic_JJ analysis_NN has_VBZ revealed_VBN that_IN the_DT Us11_JJ gene_NN product_NN is_VBZ not_RB required_VBN for_IN productive_JJ viral_JJ growth_NN in_IN cultured_JJ cells_NNS ._SENT A_DT role_NN for_IN Us11_NP in_IN the_DT regulation_NN of_IN viral_JJ protein_NN synthesis_NN emerged_VBD from_IN the_DT genetic_JJ analysis_NN of_IN HSV-1_JJ gamma34.5_NN mutants_NNS ._SENT In_IN a_DT variety_NN of_IN cultured_JJ cell_NN lines_NNS ,_, gamma34.5_NN mutants_NNS grow_VBP poorly_RB due_JJ to_TO the_DT premature_JJ cessation_NN of_IN translation_NN prior_RB to_TO the_DT completion_NN of_IN the_DT viral_JJ life_NN cycle_NN ._SENT In_IN the_DT absence_NN of_IN the_DT gamma34.5_JJ gene_NN product_NN ,_, the_DT activated_VBN cellular_JJ PKR_NP kinase_NN phosphorylates_VBZ the_DT translation_NN initiation_NN factor_NN eIF2alpha_NN ,_, inhibiting_VBG the_DT initiation_NN of_IN protein_NN synthesis_NN ._SENT Extragenic_JJ suppressor_NN mutants_NNS selected_VBN for_IN their_PP$ restored_VBN ability_NN to_TO grow_VB and_CC synthesize_VB proteins_NNS all_DT overexpressed_JJ Us11_NN as_IN an_DT immediate-early_JJ protein_NN ._SENT Further_JJR analysis_NN of_IN Us11_JJ mutants_NNS revealed_VBD that_IN Us11_NP is_VBZ also_RB required_VBN for_IN maximal_JJ rates_NNS of_IN translation_NN when_WRB expressed_VBN in_IN its_PP$ natural_JJ context_NN late_RB in_IN infection_NN (_( M._NP Mulvey_NP and_CC I._NP Mohr_NP ,_, unpublished_JJ data_NNS )_) ._SENT Inhibition_NN of_IN PKR_NP activation_NN by_IN the_DT carboxyl-terminal_JJ 68_CD residues_NNS of_IN Us11_NP is_VBZ responsible_JJ for_IN the_DT observed_JJ effects_NNS on_IN protein_NN synthesis_NN ._SENT This_DT same_JJ segment_NN of_IN Us11_JJ binds_NNS double-stranded_JJ RNA_NP (_( dsRNA_NP )_) through_IN a_DT novel_JJ RNA-binding_NP motif_NN ,_, interacts_VBZ with_IN PKR_NP and_CC the_DT PKR_NP activator_NN PACT_NN ,_, associates_NNS with_IN 60S_JJ ribosomes_NNS and_CC polysomes_NNS ,_, contains_VBZ an_DT overlapping_JJ nucleolar_JJ retention_NN and_CC nuclear_JJ export_NN signal_NN that_WDT allows_VBZ both_DT nucleolar_JJ and_CC cytoplasmic_JJ accumulation_NN ,_, and_CC can_MD potentially_RB bind_VB to_TO a_DT variety_NN of_IN structured_JJ cellular_JJ and_CC viral_JJ RNAs_NP found_VBD in_IN infected_JJ cells_NNS ._SENT Although_IN both_CC the_DT amino-_NN and_CC carboxyl-terminal_JJ portions_NNS of_IN Us11_NP can_MD be_VB packaged_VBN into_IN virions_NNS ,_, the_DT amino-terminal_JJ 40_CD amino_NN acids_NNS have_VBP been_VBN reported_VBN to_TO possess_VB an_DT activity_NN similar_JJ to_TO that_DT of_IN transactivator_NN proteins_NNS encoded_VBN by_IN complex_JJ retroviruses_NNS ._SENT It_PP is_VBZ entirely_RB possible_JJ that_IN the_DT catalogue_NN enumerated_VBN above_IN ,_, although_IN extensive_JJ ,_, does_VBZ not_RB represent_VB a_DT comprehensive_JJ picture_NN of_IN Us11_NP 's_POS activities_NNS ._SENT Our_PP$ understanding_NN of_IN the_DT role(s)_NN played_VBN by_IN Us11_JJ molecules_NNS contained_VBN within_IN the_DT tegument_NN ,_, both_CC extremely_RB early_JJ and_CC late_JJ in_IN the_DT infectious_JJ program_NN ,_, is_VBZ also_RB far_RB from_IN complete_JJ ._SENT Indeed_RB ,_, Us11_JJ protein_NN packaged_VBN in_IN the_DT tegument_NN and_CC subsequently_RB discharged_VBN into_IN the_DT cytoplasm_NN of_IN a_DT newly_RB infected_JJ host_NN cell_NN is_VBZ not_RB sufficient_JJ to_TO overcome_VB the_DT block_NN to_TO protein_NN synthesis_NN observed_VBN in_IN cells_NNS infected_VBN with_IN a_DT gamma34.5_JJ mutant_JJ virus_NN ,_, even_RB at_IN very_RB large_JJ multiplicities_NNS of_IN infection_NN ._SENT Thus_RB ,_, although_IN ca_MD ._SENT 600_CD to_TO 1,000_CD molecules_NNS of_IN Us11_NP per_IN virion_NN enter_VBP the_DT cytosol_NN ,_, some_DT of_IN which_WDT associate_NN with_IN polyribosomes_NNS and_CC enter_VB the_DT nucleolus_NN ,_, this_DT population_NN of_IN Us11_JJ molecules_NNS might_MD engage_VB in_IN other_JJ actions_NNS that_WDT have_VBP yet_RB to_TO be_VB documented_VBN ._SENT To_TO explore_VB the_DT possibility_NN that_IN Us11_NP might_MD indeed_RB contain_VB other_JJ intrinsic_JJ activities_NNS ,_, we_PP searched_VBD for_IN cellular_JJ proteins_NNS that_WDT associate_VBP with_IN the_DT Us11_JJ polypeptide_NN ,_, since_IN the_DT interaction_NN between_IN viral_JJ and_CC host_NN proteins_NNS is_VBZ important_JJ for_IN many_JJ events_NNS in_IN the_DT viral_JJ life_NN cycle_NN ._SENT Here_RB ,_, we_PP identify_VBP the_DT cellular_JJ PAT1_JJ polypeptide_NN as_IN a_DT Us11_JJ binding-protein_NN by_IN using_VBG multiple_JJ ,_, independent_JJ assays_NNS ._SENT PAT1_JJ binds_NNS microtubules_NNS ,_, is_VBZ involved_VBN in_IN the_DT intracellular_JJ trafficking_NN of_IN amyloid_JJ precursor_NN protein_NN (_( APP_NP )_) ,_, and_CC contains_VBZ a_DT region_NN homologous_JJ to_TO kinesin_NN light_NN chain_NN (_( KLC_NP )_) ._SENT This_DT interaction_NN requires_VBZ the_DT carboxyl-terminal_JJ dsRNA-binding_NN domain_NN of_IN Us11_NP and_CC a_DT region_NN of_IN PAT1_NP that_WDT contains_VBZ homology_NN to_TO the_DT kinesin_NN light_NN chain_NN ._SENT In_IN addition_NN ,_, PAT1_NP and_CC Us11_NP colocalize_VB when_WRB ectopically_RB expressed_VBN in_IN transiently_RB transfected_JJ cells_NNS and_CC in_IN HSV-1-infected_JJ cells_NNS ._SENT The_DT association_NN between_IN a_DT viral_JJ tegument_NN protein_NN and_CC a_DT cellular_JJ protein_NN with_IN the_DT potential_NN to_TO interact_VB with_IN a_DT molecular_JJ motor_NN may_MD be_VB important_JJ for_IN the_DT intracellular_JJ movement_NN of_IN viral_JJ components_NNS ._SENT Cell_NN culture_NN ._SENT |_SYM 293T_JJ and_CC MDCK_JJ cells_NNS were_VBD propogated_VBN in_IN Dulbecco_NP modified_JJ Eagle_NP medium_NN supplemented_VBD with_IN 10_CD %_NN fetal_JJ bovine_JJ serum_NN (_( FBS_NP ;_: Gibco_NP )_) ,_, 2_CD mM_NP l-glutamine_NN ,_, 50_CD U_NN of_IN penicillin/ml_NN ,_, and_CC 50_CD mug_NN of_IN streptomycin/ml_NN ._SENT Cos-1_JJ cells_NNS were_VBD grown_VBN in_IN identical_JJ media_NNS except_IN 10_CD %_NN calf_NN serum_NN was_VBD used_VBN in_IN place_NN of_IN FBS_NP ._SENT The_DT inducible_JJ MDCK585_NP and_CC MDCK411_NP lines_NNS were_VBD grown_VBN in_IN minimal_JJ essential_JJ medium_NN supplemented_VBN with_IN 1x_NP minimal_JJ essential_JJ medium_NN nonessential_JJ amino_NN acids_NNS ,_, 10_CD %_NN FBS_NP ,_, 2_CD mM_NP l-glutamine_NN ,_, 3_CD mug_NN of_IN blasticidin/ml_NN ,_, 0.3_CD mg_NN of_IN zeocin/ml_NN ,_, 50_CD U_NN of_IN penicillin/ml_NN ,_, and_CC 50_CD mug_NN of_IN streptomycin/ml_NN as_RB described_VBD previously_RB ._SENT To_TO induce_VB the_DT production_NN of_IN PAT1_NP and_CC PAT1Delta412_NP ,_, 1_CD mug_NN of_IN tetracycline_NN (Invitrogen)/ml_NN and_CC 2_CD mM_NP sodium_NN butyrate_NN were_VBD added_VBN to_TO the_DT culture_NN media_NNS for_IN 18_CD h._JJ Construction_NN of_IN recombinant_JJ HSV-1_NP expressing_VBG a_DT GFP-Us11_JJ fusion_NN protein_NN ._SENT |_SYM The_DT HSV-1_NP Patton_NP strain_NN was_VBD used_VBN throughout_IN the_DT present_JJ study_NN ._SENT Nucleotide_NN coordinates_NNS refer_VBP to_TO the_DT published_VBN strain_NN 17_CD sequence_NN (_( GenBank_NP accession_NN no_RB ._SENT )_) ._SENT Derivatives_NNS of_IN the_DT plasmid_NP pSXZY_NN contain_VBP the_DT Us10_NP -12_CD region_NN ,_, along_RB with_IN flanking_VBG sequences_NNS (_( nucleotides_NNS 143481_CD to_TO 147040_CD )_) and_CC served_VBD to_TO target_VB the_DT Us11_JJ alleles_NNS to_TO the_DT homologous_JJ region_NN in_IN the_DT viral_JJ genome_NN ._SENT To_TO replace_VB Us11_JJ with_IN an_DT open_JJ reading_NN frame_NN (_( ORF_NP )_) that_WDT fuses_VBZ enhanced_JJ green_JJ fluorescent_JJ protein_NN (_( EGFP_NP )_) coding_VBG sequences_NNS in_IN frame_NN to_TO the_DT first_JJ ATG_NP of_IN the_DT Us11_JJ gene_NN ,_, pSXZY_NN was_VBD digested_VBN with_IN XhoI_NP ,_, the_DT 5_CD '_POS overhangs_NNS were_VBD filled_VBN in_IN with_IN the_DT Klenow_NP fragment_NN ,_, and_CC the_DT plasmid_NN was_VBD subsequently_RB cleaved_VBN with_IN BspEI_NP ._SENT The_DT plasmid_NP pEGFP-Us11_NN contains_VBZ the_DT entire_JJ EGFP_NP ORF_NP fused_VBD to_TO the_DT first_JJ ATG_NP of_IN the_DT Us11_JJ gene_NN and_CC produces_VBZ an_DT EGFP-Us11_JJ fusion_NN protein_NN under_IN the_DT control_NN of_IN the_DT human_JJ cytomegalovirus_NN promoter_NN ._SENT After_IN cleavage_NN of_IN pEGFP-Us11_NN with_IN AgeI_NP ,_, the_DT 5_CD '_POS overhangs_NNS were_VBD filled_VBN in_IN with_IN the_DT Klenow_NP fragment_NN ,_, and_CC the_DT plasmid_NN was_VBD digested_VBN with_IN BspEI_NP ,_, releasing_VBG an_DT 898-bp_JJ fragment_NN that_WDT contains_VBZ the_DT EGFP-Us11_JJ fusion_NN gene_NN ._SENT This_DT fragment_NN was_VBD ligated_VBN into_IN XhoI_NP (filled)-_NN and_CC BspEI-digested_JJ pSXZY_NN to_TO create_VB pSXZY-GFP-Us11_JJ ._SENT After_IN cleavage_NN with_IN PvuII_NP to_TO release_VB the_DT HSV-1_JJ sequences_NNS from_IN the_DT plasmid_NP backbone_NN ,_, 10_CD mug_NN of_IN digested_VBN plasmid_NP DNA_NP was_VBD cotransfected_JJ ,_, along_RB with_IN purified_VBN GFPDeltaUs11_JJ viral_JJ DNA_NN ,_, into_IN Vero_NP cells_NNS ._SENT EGFP-positive_JJ plaques_NNS were_VBD subjected_VBN to_TO two_CD rounds_NNS of_IN purification_NN ._SENT The_DT physical_JJ structure_NN of_IN the_DT viral_JJ recombinants_NNS was_VBD confirmed_VBN by_IN Southern_JJ analysis_NN ,_, and_CC labeling_VBG of_IN viral_JJ proteins_NNS was_VBD performed_VBN as_IN described_VBN previously_RB ._SENT Proteins_NNS ._SENT |_SYM GSTDelta1-87_NP ,_, GSTDelta88-155_NP ,_, and_CC GST-RXP_NP have_VBP been_VBN described_VBN ._SENT In_IN vitro-translated_JJ PAT1_NP was_VBD generated_VBN with_IN the_DT TNT_NP quick-coupled_JJ reticulolysate_NN system_NN according_VBG to_TO the_DT manufacturer_NN 's_POS instructions_NNS (_( Promega_NP )_) ._SENT Plasmids_NNS ._SENT |_SYM The_DT plasmids_NNS expressing_VBG PAT1_NP or_CC PAT1Delta412_NP in_IN pCDNA4TO_NP have_VBP been_VBN described_VBN ._SENT To_TO generate_VB the_DT amino-terminal_JJ fragments_NNS Delta281_NP ,_, Delta352_NP ,_, and_CC Delta436_NP ,_, stop_NN codons_NNS were_VBD introduced_VBN into_IN the_DT PAT1_JJ coding_VBG sequence_NN by_IN PCR_NP ._SENT PAT1_JJ cDNA_NN was_VBD excised_VBN from_IN the_DT pcDNA4TO_NN vector_NN with_IN KpnI_NP and_CC XhoI_NP and_CC inserted_VBN into_IN pBluescript_NN SK(+)_NN that_WDT had_VBD been_VBN digested_VBN with_IN the_DT same_JJ enzymes_NNS in_IN order_NN to_TO produce_VB a_DT plasmid_NN capable_JJ of_IN synthesizing_VBG PAT1_NP RNA_NP that_WDT could_MD be_VB translated_VBN in_IN vitro_NN ._SENT Yeast_NN two-hybrid_NN screen_NN ._SENT |_SYM The_DT yeast_NN two-hybrid_NN assay_NN was_VBD performed_VBN as_IN described_VBN according_VBG to_TO the_DT MATCHMAKER_NP two-hybrid_NN user_NN manual_NN ._SENT The_DT yeast_NN strain_NN EGY188_NP harboring_VBG the_DT reporter_NN genes_NNS LacZ_NP and_CC LEU2_NP ,_, under_IN the_DT control_NN of_IN the_DT upstream_JJ LexA_NP DNA-binding_NP domain_NN ,_, was_VBD used_VBN in_IN the_DT assay_NN ._SENT For_IN pEG-202_NN (_( a_DT bait_NN vector_NN containing_VBG the_DT LexA_NP DNA-binding_NP domain_NN )_) constructs_NNS ,_, the_DT entire_JJ ORF_NP (_( 155_CD residues_NNS )_) of_IN HSV-Us11_NP were_VBD subcloned_VBN in_IN frame_NN into_IN pEG-202_NN ._SENT The_DT bait-containing_NN vector_NN ,_, pEG-202_NN ,_, and_CC the_DT human_JJ brain_NN MATCHMAKER_NP LexA_NP cDNA_NN library_NN in_IN the_DT pJG4-5_JJ plasmid_NN were_VBD sequentially_RB transformed_VBN into_IN the_DT yeast_NN strain_NN EGY188_NP and_CC grown_VBN on_IN minimal_JJ synthetic_JJ medium_NN lacking_VBG tryptophan_NN ,_, histidine_NN ,_, leucine_NN ,_, and_CC uracil_NN to_TO select_VB potential_JJ interactors_NNS ._SENT The_DT X-Gal_JJ (_( 5-bromo-4-chloro-3-indolyl-beta-d-galactopyranoside_JJ )_) indicator_NN dye_NN was_VBD included_VBN to_TO screen_VB transformants_NNS for_IN lacZ_NN expression_NN ._SENT Approximately_RB 3_CD x_NN 106_CD clones_NNS were_VBD screened_VBN against_IN the_DT Us11_JJ bait_NN ._SENT Plasmid_NP DNA_NP isolated_VBD from_IN potential_JJ positive_JJ clones_NNS was_VBD transformed_VBN into_IN Escherichia_NP coli_NNS KC8_NP cells_NNS ._SENT Bacterial_JJ colonies_NNS selected_VBN on_IN M9_NP minimal_JJ medium_NN lacking_VBG tryptophan_NN contained_VBD the_DT library_NN plasmid_NN ,_, which_WDT was_VBD subsequently_RB isolated_VBN ,_, and_CC its_PP$ insert_NN was_VBD sequenced_JJ ._SENT To_TO map_VB the_DT interaction_NN domains_NNS ,_, deletion_NN mutants_NNS of_IN PAT1_NP were_VBD cloned_VBN into_IN pJG4-5_NN ,_, and_CC Us11Delta1-87_JJ and_CC Us11Delta88-161_JJ were_VBD cloned_VBN into_IN pEG-202_NN ._SENT The_DT pJG4-5_NN and_CC pEG-202_NN constructs_NNS were_VBD cotransformed_VBN into_IN yeast_NN strain_NN by_IN using_VBG a_DT small-scale_JJ LiAc/ssDNA/PEG_NP transformation_NN protocol_NN ._SENT The_DT transformants_NNS were_VBD plated_VBN onto_IN appropriate_JJ minimum_JJ synthetic_JJ dropout_NN media_NNS and_CC were_VBD tested_VBN for_IN beta-galactosidase_NN activity_NN ._SENT Preparation_NN of_IN protein_NN extracts_VBZ ._SENT |_SYM 293T_JJ cells_NNS seeded_VBN in_IN six-well_NN dishes_NNS were_VBD transfected_VBN with_IN either_DT wild-type_NN (_( WT_NP )_) or_CC mutant_JJ PAT1_JJ expression_NN plasmids_NNS by_IN using_VBG Lipofectamine_NP 2000_CD (_( Invitrogen_NN )_) according_VBG to_TO the_DT manufacturer_NN 's_POS specifications_NNS ._SENT After_IN 24_CD to_TO 48_CD h_NN ,_, the_DT cells_NNS were_VBD washed_VBN twice_RB with_IN 50_CD mM_NP HEPES-KOH_NP (_( pH_NN 7.4)-150_NP mM_NP NaCl-1_NP mM_NP EDTA-5_NP %_NN glycerol_NN and_CC subsequently_RB lysed_VBN in_IN the_DT same_JJ buffer_NN supplemented_VBN with_IN 0.5_CD %_NN %_NN Triton_NP X-100_NP and_CC 200_CD muM_NN phenylmethylsulfonyl_NN fluoride_NN ._SENT After_IN 10_CD min_NN on_IN ice_NN ,_, the_DT extract_NN was_VBD clarified_VBN by_IN centrifugation_NN at_IN 14,000_CD x_NN g_NN for_IN 10_CD min_NN at_IN 4C_JJ ._SENT The_DT supernatant_JJ was_VBD used_VBN as_IN the_DT source_NN of_IN recombinant_JJ PAT1_JJ protein_NN ._SENT In_IN vitro_NN binding_VBG assays_NNS ._SENT |_SYM A_DT total_JJ 100_CD mul_NN of_IN a_DT 10_CD %_NN glutathione-agarose_NN slurry_NN was_VBD equilibrated_VBN in_IN binding_JJ buffer_NN (_( 50_CD mM_NP HEPES-KOH_NP [_SYM pH_NN 7.4_CD ]_SYM ,_, 150_CD mM_NP NaCl_NP ,_, 1_CD mM_NP EDTA_NP ,_, 5_CD %_NN glycerol_NN ,_, 0.5_CD %_NN Triton_NP X-100_NP )_) and_CC mixed_VBN with_IN 1_CD mug_NN of_IN purified_VBN glutathione_NN S-transferase_NP (_( GST_NP )_) fusion_NN protein_NN for_IN 1_CD h_NN on_IN ice_NN with_IN periodic_JJ agitation_NN ._SENT The_DT beads_NNS were_VBD subsequently_RB collected_VBN by_IN centrifugation_NN and_CC suspended_VBN in_IN 1_CD ml_NN of_IN binding_JJ buffer_NN plus_CC 3_CD %_NN BSA_NP (_( fraction_NN V_CD )_) ._SENT After_IN the_DT mixture_NN was_VBD rocked_VBN for_IN 1_CD h_NN at_IN room_NN temperature_NN ,_, 3_CD mul_NN of_IN 35S-labeled_JJ PAT1_NP that_WDT was_VBD previously_RB treated_VBN with_IN micrococcal_JJ nuclease_NN or_CC various_JJ quantities_NNS of_IN an_DT extract_NN prepared_VBN from_IN 293T_JJ cells_NNS was_VBD added_VBN ._SENT Binding_JJ reactions_NNS were_VBD incubated_VBN for_IN 30_CD min_NN at_IN 30C_JJ and_CC manually_RB agitated_VBD every_DT 5_CD min_NN ._SENT The_DT beads_NNS were_VBD subsequently_RB collected_VBN by_IN centrifugation_NN and_CC washed_VBD three_CD times_NNS with_IN binding_JJ buffer_NN ,_, and_CC the_DT associated_VBN proteins_NNS were_VBD fractionated_VBN by_IN electrophoresis_NN ._SENT Whereas_IN labeled_VBN PAT1_NP was_VBD visualized_VBN after_IN exposure_NN of_IN fluorophore-impregnated_JJ gels_NNS to_TO film_NN ,_, samples_NNS containing_VBG FLAG-tagged_JJ PAT1_JJ derivatives_NNS were_VBD electrophoretically_RB transferred_VBN to_TO a_DT polyvinylidene_NN difluoride_NN (_( PVDF_NP )_) membrane_NN and_CC probed_VBN with_IN an_DT anti-FLAG_NN monoclonal_NN antibody_NN (_( Sigma_NP )_) ._SENT Antigen-antibody_NN complexes_NNS were_VBD visualized_VBN by_IN using_VBG horseradish_NN peroxidase-conjugated_JJ secondary_JJ antibodies_NNS and_CC enhanced_JJ chemiluminescence_NN (_( ECL_NP ;_: Amersham_NP )_) ._SENT For_IN far-Western_JJ analysis_NN ,_, 5-mug_JJ samples_NNS of_IN GST_NP ,_, GST-US11_NP Delta1-87_NP ,_, and_CC GST-Us11_NP Delta88-155_NP were_VBD subjected_VBN to_TO sodium_NN dodecyl_NN sulfate-polyacrylamide_NN gel_NN electrophoresis_NN (_( SDS-PAGE_NP )_) and_CC subsequently_RB transferred_VBN to_TO a_DT PVDF_NP membrane_NN ._SENT Renaturation_NN of_IN the_DT immobilized_VBN polypeptides_NNS was_VBD accomplished_VBN by_IN washing_VBG the_DT membrane_NN once_RB for_IN 10_CD min_NN in_IN PBB_NP (_( 50_CD mM_NP Tris-HCl_NP [_SYM pH_NN 8.0_CD ]_SYM ,_, 150_CD mM_NP NaCl_NP ,_, 10_CD %_NN glycerol_NN ,_, 1_CD mM_NP dithiothreitol_NN ,_, 100_CD muM_NN phenylmethylsulfonyl_NN fluoride_NN )_) ,_, followed_VBN by_IN an_DT overnight_JJ incubation_NN in_IN PBB_NP at_IN 4C_NP ._SENT Nonspecific_JJ binding_JJ sites_NNS were_VBD next_RB blocked_VBN in_IN PBB_NP plus_CC 3_CD %_NN nonfat_NN dry_JJ milk_NN for_IN 4_CD h_NN at_IN 4C_JJ ._SENT The_DT membrane_NN was_VBD probed_VBN with_IN in_IN vitro-translated_JJ 35S-labeled_JJ PAT1_NN or_CC luciferase_NN for_IN 24_CD h_NN at_IN 4C_JJ ._SENT After_IN five_CD washes_VBZ at_IN room_NN temperature_NN with_IN PBB_NP plus_CC 0.1_CD %_NN NP-40_NP (_( 10_CD min_NN for_IN each_DT wash_NN )_) ,_, the_DT membrane_NN was_VBD air_NN dried_VBN and_CC exposed_VBN to_TO either_CC a_DT phosphorimager_NN screen_NN or_CC film_NN ._SENT Immunofluorescence_NN ._SENT |_SYM Cells_NP were_VBD seeded_VBN on_IN coverslips_NNS and_CC processed_VBN for_IN immunofluorescence_NN as_RB described_VBD previously_RB ._SENT Briefly_RB ,_, Cos-1_NP or_CC MDCK_NP cells_NNS were_VBD seeded_VBN onto_IN glass_NN coverslips_NNS for_IN 24_CD h._NN After_IN transfection_NN of_IN the_DT appropriate_JJ expression_NN plasmids_NNS with_IN Lipofectamine_NP 2000_CD (_( Invitrogen_NP )_) ,_, the_DT cells_NNS were_VBD fixed_VBN with_IN 3.7_CD %_NN paraformaldehyde_NN ,_, quenched_VBN with_IN 100_CD mM_NP NH4Cl_NP ,_, and_CC permeabilized_VBD with_IN 0.1_CD %_NN Triton_NP X-100_NP ._SENT Samples_NNS were_VBD next_RB incubated_VBN with_IN anti-FLAG_NP M2_NP primary_JJ antibody_NN (_( Sigma_NP )_) for_IN 30_CD min_NN at_IN 37C_JJ ,_, followed_VBN by_IN the_DT addition_NN of_IN a_DT Texas_NP red-conjugated_JJ secondary_JJ antibody_NN (_( Vector_NP Laboratories_NPS )_) ._SENT Nuclei_NNS were_VBD stained_VBN with_IN Hoechst_NP stain_NN ._SENT Visualization_NN ,_, quantitative_JJ analysis_NN ,_, and_CC photography_NN were_VBD performed_VBN by_IN using_VBG a_DT Zeiss_NP Axioplan_NP 2_CD fluorescence_NN microscope_NN equipped_VBN with_IN a_DT filter_NN for_IN detecting_VBG rhodamine_NN and_CC fluoroscein_NN ._SENT For_IN confocal_JJ studies_NNS ,_, Cos-1_NP cells_NNS were_VBD seeded_VBN onto_IN 35-mm_JJ dishes_NNS (_( MatTek_NP Corp._NP )_) and_CC ,_, when_WRB the_DT cells_NNS achieved_VBD 70_CD %_NN confluence_NN ,_, they_PP were_VBD transfected_VBN with_IN plasmids_NNS expressing_VBG WT_NP PAT1_NP or_CC PAT1Delta412_NP ._SENT At_IN 48_CD h_NN posttransfection_NN ,_, the_DT cells_NNS were_VBD infected_VBN with_IN GFP-Us11R_NP at_IN an_DT MOI_NP of_IN 5_CD ._SENT The_DT samples_NNS were_VBD processed_VBN at_IN various_JJ times_NNS postinfection_NN as_RB described_VBD above_IN and_CC observed_VBD by_IN using_VBG a_DT Zeiss_NP Axiovert_NP 100_CD M_NP confocal_JJ microscope_NN ._SENT PAT1_NP is_VBZ a_DT Us11_JJ interacting_VBG protein_NN ._SENT |_SYM To_TO identify_VB Us11_JJ interacting_VBG proteins_NNS ,_, we_PP performed_VBD a_DT yeast_NN two-hybrid_NN screen_NN ._SENT The_DT entire_JJ Us11_NP ORF_NP was_VBD fused_VBN to_TO the_DT LexA_NP DNA-binding_NP domain_NN and_CC cotransformed_JJ with_IN a_DT LacZ_NP reporter_NN plasmid_NN into_IN the_DT EGY188_NP yeast_NN strain_NN ._SENT The_DT yeast_NN cells_NNS were_VBD subsequently_RB transformed_VBN with_IN a_DT human_JJ brain_NN cDNA_NN library_NN fused_VBD to_TO a_DT synthetic_JJ activation_NN domain_NN ._SENT Proteins_NNS that_WDT associate_VBP with_IN Us11_NP will_MD activate_VB transcription_NN of_IN the_DT lacZ_NN gene_NN via_IN the_DT fusion_NN to_TO the_DT synthetic_JJ activation_NN domain_NN ._SENT Three_CD million_CD clones_NNS were_VBD screened_VBN ,_, and_CC four_CD clones_NNS were_VBD isolated_VBN that_WDT interact_VBP with_IN the_DT full-length_JJ Us11_JJ protein_NN (_( M._NP Mulvey_NP and_CC I._NP Mohr_NP ,_, unpublished_JJ data_NNS )_) ._SENT One_CD of_IN these_DT clones_NNS fused_VBD amino_NN acids_NNS 41_CD to_TO 585_CD of_IN PAT1_NP to_TO the_DT synthetic_JJ activation_NN domain_NN and_CC was_VBD selected_VBN for_IN further_JJR study_NN ._SENT PAT1_NP (_( named_VBN for_IN protein_NN interacting_VBG with_IN APP_NP tail-1_NP )_) was_VBD originally_RB identified_VBN in_IN a_DT yeast_NN two-hybrid_NN screen_NN as_IN a_DT protein_NN that_WDT binds_VBZ the_DT basolateral_JJ sorting_VBG sequence_NN contained_VBN in_IN the_DT APP_NP ._SENT APP_NP is_VBZ a_DT proteolytically_RB processed_VBN transmembrane_NN protein_NN that_WDT is_VBZ involved_VBN in_IN the_DT pathogenesis_NN of_IN Alzheimer_NP 's_POS disease_NN ._SENT PAT1_JJ binds_NNS microtubules_NNS and_CC is_VBZ involved_VBN in_IN the_DT intracellular_JJ trafficking_NN of_IN APP_NP ._SENT Recent_JJ data_NNS indicate_VBP that_IN PAT1_NP may_MD also_RB participate_VB in_IN intracellular_JJ signaling_VBG mediated_VBN by_IN the_DT cytoplasmic_JJ tail_NN of_IN APP_NP ._SENT The_DT central_JJ region_NN of_IN the_DT 585-residue_JJ PAT1_JJ protein_NN contains_VBZ a_DT 35-amino-acid_JJ segment_NN predicted_VBD to_TO adopt_VB the_DT structure_NN of_IN a_DT coiled_VBN coil_NN ,_, and_CC the_DT carboxyl-terminal_JJ portion_NN includes_VBZ a_DT region_NN with_IN homology_NN to_TO kinesin_NN light_NN chain_NN ._SENT PAT1_NP specifically_RB associates_NNS with_IN 68_CD residues_NNS within_IN the_DT carboxyl_NN terminus_NN of_IN Us11_NP ._SENT |_SYM Many_JJ of_IN the_DT activities_NNS ascribed_VBN to_TO the_DT Us11_JJ protein_NN reside_VB within_IN the_DT carboxyl-terminal_JJ 68_CD residues_NNS ._SENT A_DT repetitive_JJ motif_NN composed_VBN of_IN the_DT amino_NN acids_NNS Arg-X-Pro_NP comprises_VBZ a_DT novel_JJ dsRNA-binding_NN domain_NN and_CC is_VBZ thought_VBN to_TO fold_VB into_IN a_DT type_NN II_NP polyprolyl_NN alpha-helix_NN ._SENT This_DT segment_NN of_IN Us11_NP also_RB associates_NNS with_IN ribosomes_NNS ,_, interacts_VBZ with_IN PKR_NP and_CC PACT_NP ,_, inhibits_VBZ PKR_NP activation_NN ,_, and_CC contains_VBZ interwoven_VBN nucleolar_JJ retention_NN and_CC nuclear_JJ export_NN signals_NNS ,_, allowing_VBG nucleolar_JJ accumulation_NN ,_, along_RB with_IN subsequent_JJ translocation_NN to_TO the_DT cytosol_NN ._SENT To_TO discern_VB which_WDT segment_NN of_IN Us11_JJ associates_NNS with_IN PAT1_NP ,_, the_DT ability_NN of_IN PAT1_NP to_TO complex_JJ with_IN a_DT portion_NN of_IN the_DT Us11_JJ protein_NN fused_VBN to_TO GST_NP was_VBD evaluated_VBN ._SENT Full-length_JJ PAT1_NN was_VBD translated_VBN in_IN vitro_NN and_CC incubated_VBN with_IN either_DT purified_VBN GST_NP ,_, GST_NP fused_VBD to_TO the_DT carboxyl-terminal_JJ 68_CD amino_NN acids_NNS of_IN Us11_NP (_( GST-Us11Delta1-87_NP )_) ,_, or_CC GST_NP fused_VBD to_TO the_DT amino-terminal_JJ 87_CD amino_NN acids_NNS of_IN Us11_NP (_( GST-Us11Delta88-155_NP )_) ._SENT After_IN the_DT isolation_NN of_IN GST-containing_NP proteins_NNS on_IN glutathione-agarose_JJ beads_NNS ,_, associated_JJ proteins_NNS were_VBD fractionated_VBN by_IN SDS-PAGE_NP and_CC visualized_VBN by_IN fluorography_NN ._SENT Figure_NN demonstrates_VBZ that_IN the_DT full-length_JJ PAT1_JJ protein_NN associates_NNS with_IN a_DT GST_JJ fusion_NN protein_NN that_WDT contains_VBZ the_DT carboxyl-terminal_JJ 68_CD amino_NN acids_NNS of_IN Us11_JJ and_CC not_RB with_IN GST-Us11Delta88-155_NP or_CC GST_NP ._SENT Labeled_VBN PAT1_JJ also_RB bound_VBN GST-Us11Delta1-87_JJ in_IN a_DT far-Western_JJ assay_NN ._SENT GST_NP ,_, GST-Us11Delta1-87_JJ ,_, and_CC GST-Us11Delta88-161_NP were_VBD subjected_VBN to_TO SDS-PAGE_NP ,_, transferred_VBN to_TO nitrocellulose_NN ,_, renatured_JJ ,_, and_CC probed_VBN with_IN labeled_VBN PAT1_JJ ._SENT Only_RB the_DT immoblized_JJ GST-Us11Delta1-87_JJ protein_NN bound_VBN the_DT PAT1_JJ polypeptide_NN ._SENT A_DT labeled_VBN luciferase_NN probe_NN did_VBD not_RB associate_NN with_IN any_DT of_IN the_DT proteins_NNS immobilized_VBN on_IN the_DT filter_NN (_( not_RB shown_VBN )_) ._SENT Together_RB ,_, these_DT in_IN vitro_NN assays_NNS provide_VBP multiple_JJ ,_, independent_JJ physical_JJ lines_NNS of_IN evidence_NN that_WDT confirm_VBP the_DT PAT1-Us11_JJ association_NN discovered_VBN in_IN the_DT yeast_NN two-hybrid_NN screen_NN and_CC further_RBR delineate_VB the_DT PAT1_JJ binding_JJ site_NN on_IN the_DT Us11_JJ protein_NN ._SENT In_IN addition_NN ,_, PAT1_NP does_VBZ not_RB interact_VB with_IN GST-RXP_NP ,_, a_DT GST_JJ fusion_NN protein_NN containing_VBG 36_CD amino_NN acids_NNS from_IN the_DT Epstein-Barr_NP virus_NN SM_NN polypeptide_NN ._SENT GST-RXP_NP contains_VBZ eight_CD iterations_NNS of_IN the_DT RXP_NP repeat_NN sequence_NN ,_, binds_VBZ RNA_NP ,_, associates_NNS with_IN PKR_NP ,_, and_CC inhibits_VBZ PKR_NP activation_NN ._SENT Thus_RB ,_, although_IN a_DT different_JJ protein_NN containing_VBG RXP_NP repeats_NNS can_MD execute_VB a_DT number_NN of_IN Us11-related_JJ functions_NNS ,_, only_RB the_DT RXP_NP segment_NN derived_VBN from_IN Us11_JJ associates_NNS with_IN PAT1_NP ._SENT PAT1_NP residues_NNS 412_CD to_TO 585_CD containing_VBG the_DT kinesin_NN light-chain_NN homology_NN region_NN are_VBP required_VBN to_TO interact_VB with_IN the_DT C-terminal_JJ domain_NN of_IN Us11_NP ._SENT |_SYM To_TO determine_VB the_DT region(s)_NN of_IN the_DT PAT1_JJ protein_NN important_JJ for_IN binding_VBG to_TO Us11_NP ,_, a_DT series_NN of_IN PAT1_JJ deletion_NN mutants_NNS was_VBD constructed_VBN ,_, and_CC the_DT resulting_VBG polypeptides_NNS were_VBD expressed_VBN both_CC in_IN yeast_NN cells_NNS ,_, as_IN fusions_NNS to_TO the_DT synthetic_JJ activation_NN domain_NN ,_, and_CC in_IN mammalian_JJ cells_NNS ._SENT PAT1_JJ fusions_NNS expressed_VBN in_IN yeast_NN were_VBD examined_VBN for_IN their_PP$ ability_NN to_TO associate_NN with_IN LexA-Us11_JJ fusion_NN proteins_NNS and_CC to_TO activate_VB transcription_NN of_IN a_DT beta-galactosidase_NN reporter_NN gene_NN ._SENT Only_RB the_DT full-length_NN ,_, WT_NP PAT1_NP protein_NN and_CC a_DT 40-amino-acid_JJ amino-terminal_JJ deletion_NN were_VBD able_JJ to_TO associate_VB with_IN Us11_JJ or_CC Us11Delta1-87_JJ ._SENT Amino-terminal_NP PAT1_NP fragments_VBZ ranging_VBG in_IN size_NN from_IN 281_CD to_TO 436_CD amino_NN acids_NNS ,_, although_IN expressed_VBN at_IN similar_JJ levels_NNS (_( not_RB shown_VBN )_) ,_, were_VBD unable_JJ to_TO associate_NN with_IN Us11_NP and_CC activate_VB beta-galactosidase_NN transcription_NN (_( Table_NN and_CC Fig._NN )_) ._SENT Extracts_VBZ prepared_JJ from_IN mammalian_JJ cells_NNS expressing_VBG these_DT FLAG-tagged_JJ PAT1_JJ amino-terminal_JJ fragments_NNS were_VBD incubated_VBN with_IN equal_JJ amounts_NNS of_IN purified_VBN GST_JJ ,_, GST-Us11Delta1-87_JJ ,_, or_CC GST-Us11Delta88-155_NP ._SENT Glutathione-agarose-bound_JJ complexes_NNS were_VBD collected_VBN ,_, fractionated_VBN in_IN SDS-polyacrylamide_NN gels_NNS ,_, transferred_VBN to_TO nitrocellulose_NN ,_, and_CC incubated_VBD with_IN an_DT anti-FLAG_NN antibody_NN ._SENT Although_IN similar_JJ amounts_NNS of_IN FLAG-tagged_NP PAT1_NP were_VBD present_JJ in_IN the_DT various_JJ extracts_VBZ ,_, only_RB the_DT full-length_JJ PAT1_JJ protein_NN was_VBD able_JJ to_TO associate_VB with_IN GST-Us11Delta1-87_JJ (_( Fig._NN to_TO D_NP )_) ._SENT Thus_RB ,_, sequences_NNS in_IN the_DT carboxyl-terminal_JJ 149_CD amino_NN acids_NNS of_IN PAT1_NP are_VBP important_JJ for_IN binding_VBG to_TO Us11_NP ._SENT Us11_JJ expression_NN alters_VBZ the_DT subcellular_JJ distribution_NN of_IN PAT1_NP in_IN transfected_JJ cells_NNS ._SENT |_SYM To_TO discern_VB whether_IN the_DT physical_JJ association_NN of_IN PAT1_NP and_CC Us11_NP could_MD affect_VB the_DT localization_NN of_IN the_DT two_CD polypeptides_NNS in_IN intact_JJ mammalian_JJ cells_NNS ,_, the_DT subcellular_JJ distribution_NN of_IN the_DT proteins_NNS ,_, individually_RB and_CC in_IN tandem_NN ,_, was_VBD evaluated_VBN by_IN fluorescence_NN microscopy_NN ._SENT A_DT fusion_NN of_IN Us11_JJ protein_NN coding_VBG sequences_NNS to_TO EGFP_NP was_VBD used_VBN to_TO visualize_VB Us11_JJ ,_, whereas_IN PAT1_NP tagged_VBN with_IN a_DT FLAG_NP epitope_NN was_VBD identified_VBN by_IN indirect_JJ immunofluoresence_NN ._SENT In_IN contrast_NN to_TO the_DT pattern_NN displayed_VBN by_IN EGFP_NP after_IN transfection_NN into_IN MDCK_NP cells_NNS ,_, EGFP-Us11_NP accumulated_VBD most_JJS intensely_RB in_IN the_DT nucleolus_NN and_CC diffusely_RB stained_VBD the_DT nucleoplasm_NN ._SENT EGFP-Us11_NP was_VBD also_RB present_JJ in_IN the_DT cytosol_NN ,_, albeit_IN in_IN much_RB smaller_JJR amounts_NNS ._SENT PAT1_NP ,_, however_RB ,_, was_VBD predominantly_RB concentrated_VBN in_IN the_DT nucleus_NN and_CC exhibited_VBN nucleolar_JJ sparing_VBG ._SENT Numerous_JJ small_JJ ,_, discrete_JJ PAT1_JJ foci_NNS were_VBD observed_VBN in_IN the_DT cytosol_NN as_IN well_RB ._SENT A_DT mutant_JJ derivative_NN of_IN PAT1_NP that_WDT lacks_VBZ residues_NNS 412_CD to_TO 585_CD (_( Delta412_NP )_) accumulated_VBD diffusely_RB in_IN the_DT cytosol_NN and_CC exhibited_VBN areas_NNS of_IN more_JJR intense_JJ punctate_JJ staining_VBG in_IN the_DT perinuclear_JJ region_NN ._SENT These_DT data_NNS ,_, concerning_VBG the_DT intracellular_JJ localization_NN of_IN each_DT protein_NN expressed_VBD individually_RB ,_, agree_VBP with_IN previously_RB published_VBN reports_NNS and_CC serve_VBP to_TO validate_VB our_PP$ assay_NN ._SENT Experiments_NNS examining_VBG the_DT localization_NN of_IN PAT1_NP and_CC Us11_NP expressed_VBD together_RB in_IN the_DT same_JJ cell_NN were_VBD conducted_VBN in_IN MDCK_NP cell_NN lines_NNS stably_RB expressing_VBG either_DT Flag-tagged_NP WT_NP PAT1_NP (_( MDCK585_NP )_) or_CC PAT1Delta412_NP (_( MDCK411_NP )_) from_IN an_DT inducible_JJ promoter_NN and_CC in_IN Cos-1_JJ cells_NNS cotransfected_VBN with_IN EGFP-Us11_JJ and_CC PAT1_JJ derivatives_NNS ._SENT In_IN MDCK585_NP cells_NNS ,_, EGFP-Us11_NP accumulated_VBD predominantly_RB in_IN the_DT perinuclear_JJ region_NN of_IN the_DT cytosol_NN ,_, as_RB did_VBD the_DT WT_NP PAT1_NP protein_NN ._SENT Indeed_RB ,_, the_DT two_CD proteins_NNS colocalized_VBN in_IN this_DT area_NN to_TO a_DT large_JJ extent_NN in_IN ca_MD ._SENT 44_CD %_NN of_IN cells_NNS that_WDT expressed_VBD both_DT proteins_NNS (_( Fig._NN and_CC C_NP )_) ._SENT Interestingly_RB ,_, very_RB little_RB ,_, if_IN any_DT ,_, EGFP-Us11_NP is_VBZ seen_VBN in_IN the_DT nucleolus_NN ,_, and_CC the_DT majority_NN of_IN the_DT PAT1_JJ protein_NN appears_VBZ to_TO be_VB excluded_VBN from_IN the_DT nucleus_NN ,_, its_PP$ normal_JJ location_NN ._SENT In_IN addition_NN to_TO colocalizing_VBG in_IN cells_NNS expressing_VBG both_DT polypeptides_NNS ,_, coexpression_NN of_IN PAT1_NP and_CC Us11_NP appears_VBZ to_TO mutually_RB alter_VB the_DT subcellular_JJ distribution_NN observed_VBD when_WRB each_DT protein_NN was_VBD expressed_VBN individually_RB ._SENT Importantly_RB ,_, this_DT analysis_NN was_VBD performed_VBN by_IN directly_RB observing_VBG a_DT number_NN of_IN individual_JJ cells_NNS ,_, unlike_IN biochemical_JJ methodologies_NNS that_WDT yield_VBP results_NNS from_IN entire_JJ populations_NNS ._SENT Therefore_RB ,_, the_DT approach_NN described_VBD here_RB is_VBZ subject_JJ to_TO variations_NNS inherent_JJ within_IN the_DT overall_JJ population_NN ,_, which_WDT might_MD reflect_VB the_DT asynchronous_JJ nature_NN of_IN the_DT culture_NN or_CC genetic_JJ heterogeneity_NN resulting_VBG from_IN its_PP$ continuous_JJ passage_NN ._SENT It_PP is_VBZ well_RB established_VBN that_IN all_DT of_IN the_DT cells_NNS within_IN a_DT population_NN ,_, especially_RB those_DT of_IN established_JJ immortalized_VBN cell_NN lines_NNS ,_, do_VBP not_RB respond_VB identically_RB to_TO a_DT variety_NN of_IN signals_NNS that_WDT regulate_VBP gene_NN expression_NN ._SENT Likewise_RB ,_, in_IN a_DT population_NN of_IN cells_NNS that_WDT coexpress_VBP two_CD polypeptides_NNS demonstrated_VBN to_TO associate_VB by_IN biochemical_JJ techniques_NNS ,_, it_PP should_MD come_VB as_IN no_DT surprise_NN that_IN these_DT proteins_NNS might_MD not_RB colocalize_VB in_IN 100_CD %_NN of_IN the_DT expressing_VBG cells_NNS ._SENT To_TO demonstrate_VB that_IN the_DT observed_JJ frequency_NN of_IN colocalization_NN depends_VBZ upon_IN PAT1_NP ,_, the_DT distribution_NN of_IN Us11_NP was_VBD evaluated_VBN in_IN cells_NNS expressing_VBG a_DT mutant_JJ PAT1_JJ derivative_NN that_WDT does_VBZ not_RB interact_VB with_IN Us11_NP ._SENT Significantly_RB ,_, the_DT PAT1_JJ mutant_JJ derivative_NN expressed_VBN in_IN MDCK411_JJ cells_NNS did_VBD not_RB colocalize_VB with_IN EGFP-Us11_NP and_CC displayed_VBD the_DT punctate_JJ cytoplasmic_JJ distribution_NN observed_VBD previously_RB ._SENT PAT1Delta412_NP and_CC Us11_NP colocalized_VBD in_IN only_RB 2.4_CD to_TO 3.2_CD %_NN of_IN cells_NNS expressing_VBG both_DT polypeptides_NNS ._SENT The_DT nucleolar_JJ accumulation_NN of_IN Us11_NP in_IN MDCK411_NP cells_NNS was_VBD restored_VBN as_RB well_RB ._SENT A_DT similar_JJ picture_NN emerged_VBD when_WRB the_DT proteins_NNS were_VBD expressed_VBN transiently_RB in_IN Cos-1_JJ cells_NNS ._SENT PAT1_NP again_RB appeared_VBD to_TO be_VB excluded_VBN from_IN the_DT nuclear_JJ compartment_NN and_CC extensively_RB colocalized_VBN with_IN Us11_NP in_IN the_DT cytoplasmic_JJ and_CC perinuclear_JJ area_NN ._SENT Thus_RB ,_, Us11_JJ expression_NN can_MD alter_VB the_DT subcellular_JJ distribution_NN of_IN PAT1_NP such_JJ that_IN it_PP is_VBZ excluded_VBN from_IN the_DT nucleus_NN ;_: furthermore_RB ,_, this_DT redistribution_NN of_IN WT_NP PAT1_NP requires_VBZ 149_CD amino_NN acids_NNS in_IN its_PP$ carboxyl_NN terminus_NN that_WDT shares_VBZ homology_NN to_TO kinesin_NN light_NN chain_NN ._SENT Intriguingly_RB ,_, whereas_IN Us11_NP is_VBZ barely_RB if_IN at_IN all_DT detectable_JJ in_IN the_DT nucleoli_NNS of_IN MDCK_NP cells_NNS that_WDT express_VBP WT_NP PAT1_NP ,_, the_DT accumulation_NN of_IN Us11_NP in_IN nucleoli_NNS of_IN Cos-1_JJ cells_NNS that_WDT express_VBP WT_NP PAT1_NP is_VBZ readily_RB discernible_JJ ._SENT Although_IN the_DT exact_JJ reason(s)_NN for_IN this_DT different_JJ behavior_NN is_VBZ not_RB immediately_RB obvious_JJ ,_, it_PP certainly_RB could_MD reflect_VB species_NN differences_NNS (_( canine_JJ versus_IN monkey_NN )_) ,_, cell_NN state_NN differences_NNS (_( nontransformed_JJ versus_CC transformed_VBN )_) ,_, or_CC the_DT levels_NNS of_IN the_DT expressed_VBN proteins_NNS achieved_VBN in_IN the_DT different_JJ cells_NNS ._SENT In_IN any_DT event_NN ,_, whereas_IN WT_NP PAT1_NP appears_VBZ to_TO be_VB capable_JJ of_IN altering_VBG the_DT subcellular_JJ distribution_NN of_IN Us11_NP in_IN both_DT MDCK_NP and_CC Cos-1_NP cells_NNS ,_, it_PP does_VBZ not_RB always_RB prevent_VB the_DT nucleolar_JJ accumulation_NN or_CC retention_NN of_IN Us11_NP in_IN transiently_RB transfected_JJ Cos-1_JJ cells_NNS ._SENT Us11_NP and_CC PAT1_NP colocalize_VBP in_IN HSV-1_JJ infected_JJ cells_NNS ._SENT |_SYM Although_IN our_PP$ studies_NNS indicate_VBP that_IN Us11_NP can_MD colocalize_VB with_IN PAT1_NP and_CC alter_VB its_PP$ subcellular_JJ distribution_NN in_IN the_DT absence_NN of_IN any_DT other_JJ HSV-1_JJ components_NNS ,_, they_PP have_VBP not_RB addressed_VBN whether_IN this_DT can_MD occur_VB in_IN infected_JJ cells_NNS ._SENT To_TO evaluate_VB the_DT distribution_NN of_IN Us11_NP and_CC PAT1_NP in_IN infected_JJ cells_NNS ,_, we_PP first_RB constructed_VBD a_DT recombinant_JJ HSV-1_NP that_WDT fused_VBD EGFP_NP coding_VBG sequences_NNS to_TO the_DT 5_CD '_POS end_NN of_IN the_DT Us11_JJ gene_NN (_( GFP-Us11R_NP ,_, Fig._NN )_) ._SENT This_DT allowed_VBD us_PP to_TO localize_VB Us11_JJ expression_NN in_IN infected_JJ cells_NNS by_IN monitoring_VBG EGFP_NP fluorescence_NN ._SENT Beginning_VBG with_IN a_DT Us11-null_NP virus_NN (_( DeltaUs11_JJ virus_NN )_) in_IN which_WDT the_DT Us11_JJ gene_NN was_VBD replaced_VBN by_IN the_DT GFP_NP ORF_NP (_( Fig._NN and_CC )_) ,_, we_PP subsequently_RB repaired_VBD the_DT mutant_JJ Us11_JJ allele_NN with_IN a_DT GFP-Us11_NP fusion_NN gene_NN ._SENT Southern_JJ analysis_NN of_IN recombinant_JJ viral_JJ genomes_NNS demonstrated_VBD that_IN Us11_JJ coding_VBG sequences_NNS had_VBD been_VBN replaced_VBN with_IN DNA_NP encoding_VBG an_DT EGFP-Us11_JJ fusion_NN protein_NN ._SENT Aside_RB from_IN producing_VBG an_DT EGFP-Us11_JJ fusion_NN protein_NN displaying_VBG an_DT apparent_JJ molecular_JJ mass_NN of_IN 50_CD kDa_NN ,_, the_DT recombinant_JJ GFP-Us11R_NP was_VBD otherwise_RB indistinguishable_JJ from_IN its_PP$ WT_NP counterpart_NN in_IN terms_NNS of_IN its_PP$ ability_NN to_TO direct_VB viral_JJ protein_NN synthesis_NN in_IN multiple_JJ cultured_JJ cell_NN lines_NNS (_( Fig._NN and_CC M._NP Mulvey_NP ,_, unpublished_JJ results_NNS )_) ._SENT EGFP-Us11_JJ expression_NN was_VBD first_RB detected_VBN in_IN nucleoli_NNS as_IN early_JJ as_IN 6_CD h_NN postinfection_NN and_CC was_VBD clearly_RB visible_JJ mainly_RB in_IN nucleoli_NNS and_CC the_DT surrounding_VBG nucleoplasm_NN by_IN 8_CD h_NN postinfection_NN ,_, a_DT finding_VBG consistent_JJ with_IN its_PP$ expression_NN as_IN a_DT true_JJ late_JJ gene_NN ._SENT Smaller_JJR quantities_NNS of_IN Us11_NP were_VBD also_RB detected_VBN in_IN the_DT cytosol_NN ._SENT To_TO assess_VB the_DT effects_NNS of_IN viral_JJ Us11_JJ expression_NN on_IN PAT1_JJ localization_NN ,_, Cos-1_NP cells_NNS were_VBD transfected_VBN with_IN vectors_NNS expressing_VBG either_DT WT_NP PAT1_NP or_CC PAT1Delta412_NP and_CC subsequently_RB infected_VBN with_IN GFP-Us11R_NP 24_CD h_NN later_RBR ._SENT At_IN various_JJ times_NNS postinfection_NN ,_, cells_NNS were_VBD fixed_VBN and_CC processed_VBN for_IN indirect_JJ immunofluoresence_NN to_TO detect_VB PAT1_JJ ._SENT Us11_JJ localization_NN was_VBD monitored_VBN by_IN the_DT intrinsic_JJ fluorescence_NN of_IN EGFP-Us11_NP ,_, and_CC confocal_JJ images_NNS were_VBD obtained_VBN ._SENT In_IN 59_CD %_NN of_IN cells_NNS expressing_VBG WT_NP PAT_NP and_CC Us11_NP ,_, PAT1_NP was_VBD excluded_VBN from_IN the_DT nucleus_NN and_CC colocalized_JJ (_( yellow_JJ signal_NN )_) with_IN the_DT majority_NN of_IN the_DT EGFP-Us11_JJ polypeptide_NN in_IN a_DT perinuclear_JJ zone_NN and_CC a_DT cytosolic_JJ patch_NN ._SENT Only_RB a_DT small_JJ fraction_NN of_IN Us11_JJ (_( green_JJ signal_NN )_) did_VBD not_RB colocalize_VB with_IN WT_NP PAT1_NP in_IN the_DT merged_JJ panel_NN ._SENT Although_IN some_DT PAT1_NP did_VBD not_RB appear_VB to_TO colocalize_VB with_IN Us11_NP in_IN the_DT merged_JJ image_NN (_( red_JJ signal_NN )_) ,_, a_DT large_JJ proportion_NN of_IN PAT1_NP clearly_RB colocalized_VBD with_IN Us11_NP ,_, as_RB indicated_VBN by_IN the_DT yellow_JJ perinuclear_NN area_NN ._SENT Perhaps_RB the_DT association_NN of_IN both_DT Us11_JJ and_CC PAT1_JJ with_IN other_JJ polypeptides_NNS accounts_NNS for_IN the_DT fraction_NN of_IN both_DT proteins_NNS that_WDT does_VBZ not_RB colocalize_VB ._SENT Indeed_RB ,_, both_DT Us11_NP and_CC PAT1_NP have_VBP been_VBN demonstrated_VBN to_TO interact_VB with_IN other_JJ cellular_JJ proteins_NNS ._SENT Finally_RB ,_, Us11_NP did_VBD not_RB accumulate_VB in_IN the_DT nucleoli_NNS of_IN PAT1-expressing_JJ cells_NNS ._SENT In_IN marked_JJ contrast_NN to_TO cells_NNS that_WDT express_VBP WT_NP PAT1_NP ,_, Us11_NP amassed_VBD in_IN the_DT nucleoli_NNS of_IN infected_JJ cells_NNS that_WDT expressed_VBD PAT1Delta412_JJ and_CC colocalized_VBN with_IN the_DT mutant_JJ PAT1_JJ protein_NN in_IN only_RB 6.25_CD %_NN of_IN cells_NNS coexpressing_VBG the_DT two_CD polypeptides_NNS ._SENT Thus_RB ,_, the_DT subcellular_JJ distribution_NN of_IN PAT1_NP was_VBD altered_VBN in_IN infected_JJ cells_NNS in_IN a_DT manner_NN that_WDT required_VBD its_PP$ carboxyl-terminal_JJ 149_CD residues_NNS ._SENT Moreover_RB ,_, Us11_NP can_MD colocalize_VB with_IN PAT1_NP in_IN HSV-1_NP infected_JJ cells_NNS and_CC failed_VBD to_TO accumulate_VB in_IN the_DT nucleoli_NNS of_IN infected_JJ cells_NNS expressing_VBG the_DT WT_NP PAT1_NP polypeptide_NN ._SENT To_TO determine_VB whether_IN Us11_NP was_VBD required_VBN for_IN the_DT redistribution_NN of_IN PAT1_NP in_IN HSV-1_NP infected_JJ cells_NNS ,_, Cos-1_JJ cells_NNS transfected_VBN with_IN a_DT plasmid_NN expressing_VBG WT_NP PAT1_NP were_VBD infected_VBN with_IN either_DT GFP-Us11R_NP or_CC DeltaUs11_NP recombinant_JJ viruses_NNS ._SENT At_IN 10_CD h_NN postinfection_NN ,_, the_DT cells_NNS were_VBD fixed_VBN and_CC processed_VBN for_IN immunofluoresence_NN to_TO detect_VB PAT1_JJ ._SENT All_DT of_IN the_DT cells_NNS examined_VBD were_VBD infected_VBN as_IN evidenced_VBN by_IN their_PP$ EGFP_NP fluorescence_NN (_( data_NNS not_RB shown_VBN )_) ._SENT Figure_NN demonstrates_VBZ that_IN PAT1_NP remains_VBZ nuclear_JJ in_IN cells_NNS infected_VBN with_IN DeltaUs11_NP ,_, as_RB evidenced_VBN by_IN visible_JJ nucleolar_JJ sparing_JJ and_CC the_DT coincidence_NN of_IN Texas_NP red_NN and_CC DAPI_NP (_( 4',6'-diamidino-2-phenylindole_JJ )_) stains_NNS ._SENT However_RB ,_, in_IN cells_NNS infected_VBN with_IN a_DT virus_NN that_WDT produces_VBZ Us11_NP ,_, PAT1_NP is_VBZ predominantly_RB excluded_VBN from_IN nuclei_NNS and_CC concentrates_NNS in_IN a_DT perinuclear_JJ region_NN ._SENT Thus_RB ,_, the_DT redistribution_NN of_IN PAT1_NP from_IN the_DT nucleus_NN to_TO the_DT cytosol_NN in_IN HSV-1-infected_JJ cells_NNS depends_VBZ exclusively_RB upon_IN the_DT Us11_JJ gene_NN product_NN ._SENT Us11_NP is_VBZ a_DT multifunctional_JJ dsRNA-binding_NN protein_NN produced_VBD late_RB in_IN the_DT HSV-1_JJ productive_JJ growth_NN cycle_NN that_WDT is_VBZ required_VBN for_IN maximal_JJ rates_NNS of_IN late_JJ viral_JJ protein_NN synthesis_NN (_( ;_: Mulvey_NP and_CC Mohr_NP ,_, unpublished_JJ data_NNS )_) ._SENT The_DT carboxyl-terminal_JJ 68_CD amino_NN acids_NNS binds_VBZ a_DT variety_NN of_IN structured_JJ RNAs_NP ;_: associates_NNS with_IN 60S_JJ ribosomal_JJ subunits_NN and_CC polysomes_NNS ;_: contains_VBZ overlapping_JJ nucleolar_JJ retention_NN and_CC nuclear_JJ export_NN signals_NNS ,_, allowing_VBG nucleolar_JJ and_CC cytoplasmic_JJ accumulation_NN ;_: binds_VBZ the_DT cellular_JJ PKR_NP kinase_NN ,_, as_RB well_RB as_IN the_DT PACT_JJ kinase_NN activator_NN ;_: and_CC can_MD prevent_VB activation_NN of_IN PKR_NP ._SENT In_IN addition_NN ,_, Us11_NP is_VBZ a_DT component_NN of_IN the_DT viral_JJ tegument_NN ,_, packaged_VBN into_IN the_DT viral_JJ particle_NN between_IN the_DT envelope_NN and_CC the_DT nucleocapsid_NN ._SENT Since_IN genetic_JJ analysis_NN of_IN Us11_JJ mutants_NNS is_VBZ hampered_VBN by_IN the_DT fact_NN that_IN it_PP is_VBZ not_RB essential_JJ for_IN replication_NN in_IN any_DT cultured_JJ cell_NN lines_NNS examined_VBD to_TO date_VB ,_, we_PP chose_VBD to_TO search_VB for_IN host_NN proteins_NNS that_WDT associate_VBP with_IN Us11_NP as_IN a_DT means_NN of_IN identifying_VBG novel_NN functions_NNS that_IN Us11_NP might_MD influence_VB ._SENT We_PP now_RB report_VBP that_IN the_DT carboxyl-terminal_JJ segment_NN of_IN Us11_NP interacts_VBZ with_IN the_DT cellular_JJ PAT1_JJ polypeptide_NN ,_, a_DT microtubule-binding_NN protein_NN that_WDT participates_VBZ in_IN the_DT trafficking_NN of_IN APP_NP ._SENT A_DT region_NN of_IN PAT1_NP that_WDT contains_VBZ homology_NN to_TO kinesin_NN light_NN chain_NN is_VBZ required_VBN for_IN binding_VBG to_TO Us11_NP and_CC for_IN the_DT perinuclear_JJ colocalization_NN of_IN the_DT two_CD proteins_NNS in_IN transfected_JJ and_CC HSV-1-infected_JJ cells_NNS ._SENT The_DT association_NN between_IN PAT1_NP ,_, a_DT microtubule-binding_JJ protein_NN involved_VBN in_IN APP_NP trafficking_NN ,_, and_CC Us11_NP ,_, an_DT RNA-binding_NP tegument_NN polypeptide_NN ,_, results_NNS in_IN the_DT redis_NNS 